MUPIROCIN
Generic: MUPIROCIN
Encube EthicalsManufacturer
TOPICALRoute
MUPIROCIN CALCIUMActive Substance
2021-08-31Original Approval
MUPIROCIN is FDA application ANDA213076, sponsored by ENCUBE. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2022-04-13
Mupirocin Ointment, USP 2%, 22 grams tube, Rx only, MFG: Teva Pharma USA, NDC 0093-1010-42, MFG: Teva Pharma USAcGMP deviations: Temperature abuse
Class II2024-08-30
Mupirocin Ointment, USP, 2%, 22 g, Rx only, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513,Subpotent Drug
Top Reported Reactions
1
DRUG INEFFECTIVE
1,559 reports
2
OFF LABEL USE
983 reports
3
NAUSEA
951 reports
4
PAIN
929 reports
5
PRODUCT USE IN UNAPPROVED INDICATION
847 reports
6
MACULAR DEGENERATION
820 reports
7
FATIGUE
817 reports
8
HEADACHE
764 reports
9
DIARRHOEA
704 reports
10
RASH
612 reports